FDA Removes Bioscan Requirement for Zevalin - MPR
Links shared publicly online about this topic.
- 0total visits
FDA Removes Bioscan Requirement for Zevalin - MPR
empr.com —
View full resource at empr.com
Most Recently Shared on November 21, 2011 at 2:28 pm By:
FDA Removes Bioscan Requirement for Zevalin http://t.co/yNwKV12U #lymphoma
ZEVALIN® (ibritumomab tiuxetan) - Targeted. Proven. Today.
zevalin.com — “ZEVALIN (ibritumomab tiuxetan) from Spectrum Pharmaceuticals is a CD20-directed radiotherapeutic antibody.” View full resource at zevalin.com
Most Recently Shared on November 21, 2011 at 10:02 pm By:
Kristin Gustafson Patient Advocate and Health Business Administrator
FDA removes bioscan requirements from Zevalin http://t.co/DKkvbkNd
Spectrum's Prior Approval Supplement for Indium-111 ZEVALIN accepted for review by FDA
news-medical.net — “Spectrum Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the Prior Approval Supplement containing data providing for the removal of the Indium-111 ZEVALIN® (ibritumomab tiuxetan) pre-treatment imaging evaluation, more commonly referred to as the "bioscan" requirement.” View full resource at news-medical.net
Most Recently Shared on March 23, 2011 at 7:55 am By:
News-Medical.Net Health News and Oncology
Oncology News: Spectrum's Prior Approval Supplement for Indium-111 ZEVALIN accepted for review by FDA: Spectrum ... http://bit.ly/fsrqm5
Spectrum Pharmaceuticals Submits Data To FDA In Support Of Bioscan Removal For ZEVALIN(R)
medicalnewstoday.com — “Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, announced that on Thursday, J” View full resource at medicalnewstoday.com
Most Recently Shared on January 26, 2011 at 2:05 pm By:
Spectrum Pharmaceuticals Submits Data To FDA In Support Of Bioscan Removal For ZEVALIN(R) http://mnt.to/3QrR #lymphoma #leukemia
StreetInsider.com - Spectrum Pharmaceuticals Submits Data to FDA in Support of Bioscan Removal for ZEVALIN®
streetinsider.com — “StreetInsider.com - Spectrum Pharmaceuticals Submits Data to FDA in Support of Bioscan Removal for ZEVALIN®” View full resource at streetinsider.com
Most Recently Shared on January 25, 2011 at 12:03 am By:
JanCerny, MD, PhD Hematologist, Physician, Doctor, PhD, Internist, and Oncologist
Spectrum Pharmaceuticals Submits Data to FDA in Support of Bioscan Removal for ZEVALIN® http://ow.ly/3Ju0q
Advertisement
